|
LOC100128640 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.33360003227313E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.01920002729628E-09 |
| Normal-vs-Stage2 |
8.1705000000043E-05 |
| Normal-vs-Stage3 |
3.12640000554865E-08 |
| Normal-vs-Stage4 |
2.14259999964383E-07 |
| Stage1-vs-Stage2 |
2.639800E-01 |
| Stage1-vs-Stage3 |
9.293400E-01 |
| Stage1-vs-Stage4 |
9.923000E-01 |
| Stage2-vs-Stage3 |
3.061000E-01 |
| Stage2-vs-Stage4 |
3.551800E-01 |
| Stage3-vs-Stage4 |
9.476800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6342000520051E-09 |
| Normal-vs-AfricanAmerican |
2.759300E-03 |
| Normal-vs-Asian |
1.65490000036961E-07 |
| Caucasian-vs-AfricanAmerican |
3.704800E-01 |
| Caucasian-vs-Asian |
5.163800E-01 |
| AfricanAmerican-vs-Asian |
5.837000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63489999818844E-08 |
| Normal-vs-Female |
3.16649995113494E-09 |
| Male-vs-Female |
1.198350E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.41660002909106E-09 |
| Normal-vs-Age(41-60Yrs) |
3.21540000181031E-08 |
| Normal-vs-Age(61-80Yrs) |
3.31470000336509E-08 |
| Normal-vs-Age(81-100Yrs) |
5.842300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.486400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.585800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.448400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.715800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.740400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.211400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.406400E-01 |
| Classical-VS-Follicular |
2.922400E-01 |
| Classical-VS-Other |
7.580800E-01 |
| Classical-VS-Normal |
5.8260000046495E-08 |
| Tall-VS-Follicular |
6.553400E-01 |
| Tall-VS-Other |
3.630800E-01 |
| Tall-VS-Normal |
4.31629999519956E-08 |
| Follicular-VS-Other |
5.680600E-01 |
| Follicular-VS-Normal |
3.28289999629305E-08 |
| Other-VS-Normal |
4.000100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29839999862824E-08 |
| Normal-vs-N1 |
5.27999999277995E-09 |
| N0-vs-N1 |
3.762600E-01 |
|
|
